Time To Start

In a recent interview with Forbes' Matthew Herper, Dendreon's retiring chief scientist, David Urdal, weighs in on the lack of new drugs in the past few years. When Herper asks him why the drug business is "in such a profound innovation drought," Urdal says the dynamics of drug innovation have changed from when he began to work in the biotech industry.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.